Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DRTS

Alpha Tau Medical (DRTS)

Alpha Tau Medical Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRTS
DateTimeSourceHeadlineSymbolCompany
12/18/20248:30AMGlobeNewswire Inc.Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update DayNASDAQ:DRTSAlpha Tau Medical Ltd
12/17/20249:00AMGlobeNewswire Inc.Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as AdvisorNASDAQ:DRTSAlpha Tau Medical Ltd
12/11/20248:30AMGlobeNewswire Inc.Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
12/06/20248:30AMGlobeNewswire Inc.Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors SymposiumNASDAQ:DRTSAlpha Tau Medical Ltd
11/19/20244:00PMGlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
11/13/20248:30AMGlobeNewswire Inc.Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
10/21/20248:30AMGlobeNewswire Inc.Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeNASDAQ:DRTSAlpha Tau Medical Ltd
10/10/20248:30AMGlobeNewswire Inc.Alpha Tau Treats First Patient with Recurrent Lung CancerNASDAQ:DRTSAlpha Tau Medical Ltd
09/20/20248:30AMGlobeNewswire Inc.Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCCNASDAQ:DRTSAlpha Tau Medical Ltd
08/22/20248:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
08/22/20248:30AMGlobeNewswire Inc.Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor ConNASDAQ:DRTSAlpha Tau Medical Ltd
08/14/20244:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
08/14/20244:02PMGlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
08/14/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
06/25/20248:30AMGlobeNewswire Inc.Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial CancersNASDAQ:DRTSAlpha Tau Medical Ltd
05/21/20248:45AMGlobeNewswire Inc.Alpha Tau to Present at the Jefferies Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
05/20/20244:01PMGlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
05/13/20248:30AMGlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSAlpha Tau Medical Ltd
05/06/20248:30AMGlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSAlpha Tau Medical Ltd
05/01/20248:30AMGlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
03/25/20248:50AMGlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSAlpha Tau Medical Ltd
03/07/20244:13PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRTSAlpha Tau Medical Ltd
03/07/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
03/07/20244:01PMGlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
02/26/20248:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
02/26/20248:30AMGlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
12/20/20239:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
12/20/20239:15AMGlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
12/18/202311:09AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
11/29/20238:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:DRTS